SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Merrill Lynch MITTS ML EuroFund Index due 2/28/2006 (EFM) trades at a trailing P/E of 76.3. Trailing earnings yield is 1.31%.
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 76.3).
- Trailing Earnings Yield 1.31% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 53/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EFM
Valuation Multiples
P/E (TTM)76.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio111.67
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.34
Book Value / Share$0.00
Revenue / Share$0.23
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.31%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2010 |
$10.64 |
$2.55B |
$1.89B |
74% |
| 2011 |
$0.00 |
$2.39B |
$0.00 |
0% |
| 2012 |
$4.89 |
$10.3B |
$868.36M |
8.4% |
| 2013 |
$4.09 |
$9.1B |
$730.57M |
8% |
| 2014 |
$5.33 |
$9.77B |
$960.26M |
9.8% |
| 2015 |
$-0.87 |
$9.45B |
$-156.73M |
-1.7% |
| 2016 |
$-3.16 |
$9B |
$-564.5M |
-6.3% |
| 2017 |
$2.36 |
$9.42B |
$425.35M |
4.5% |
| 2018 |
$4.70 |
$11.01B |
$862.56M |
7.8% |
| 2019 |
$0.34 |
$1.29B |
$1.9B |
146.4% |
